Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DRUID is a digital health company that has developed a rapid, non-invasive, and objective mobile application for measuring cognitive and motor impairment. The technology, originally developed to detect impairment from cannabis and alcohol, uses a series of tasks to assess a user's reaction time, hand-eye coordination, and balance. Beyond workplace safety, the DRUID platform is increasingly utilized in clinical research and pharmaceutical trials to monitor the central nervous system (CNS) effects of various therapeutic candidates. The company's mission is to provide a standardized, data-driven alternative to subjective field sobriety tests and self-reporting in both commercial and clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DRUID.